Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v2.3.0.15
Consolidated Statements Of Cash Flows (USD $)
 9 Months Ended
Aug. 31, 2011
Aug. 31, 2010
Cash Flows from Operating Activities:    
Net (loss) income $ (1,971,568) [1] $ 3,121,866 [1]
Adjustments to reconcile net (loss) income to net cash provided by operating activities:    
Depreciation and amortization expense 428,540 437,126 [1]
Loss on sale of property and equipment 1,214  
Compensatory element of stock options 407,244 98,460 [1]
Provision for doubtful accounts 196,555 270,460 [1]
Write-off of abandoned patents 207,571  
Equity in losses of affiliate 92,214 62,111 [1]
Deferred income tax benefit   (1,788,241) [1]
Changes in assets and liabilities:    
Accounts receivable and advances (407,136) (247,472) [1]
Prepaid expenses and other current assets (238,930) (38,811) [1]
Deposits and other assets (134,604) (54,219) [1]
Accounts payable (178,052) 252,470 [1]
Accrued expenses 1,573,842 (413,932) [1]
Deferred consulting obligation (80,255) (74,836) [1]
Deferred revenue 563,106 [1] 78,303 [1]
Net cash provided by operating activities 459,741 1,703,285 [1]
Cash flows from investing activities:    
Restricted cash held in escrow (2,500,000)  
Purchases of property and equipment (560,444) (313,666) [1]
Purchases of marketable securities and other investments   (1,035,000) [1]
Proceeds from sale of marketable securities and other investments 130,000 863,000 [1]
Investments in patents and trademarks (48,106) (187,735) [1]
Net cash used in investing activities (2,978,550) (673,401) [1]
Cash flows from financing activities:    
Proceeds from the exercise of stock options 22,762  
Net cash provided by financing activities 22,762  
(Decrease) increase in cash and cash equivalents (2,496,047) 1,029,884 [1]
Cash and cash equivalents - beginning of period 8,369,537 [1] 6,850,765 [1]
Cash and cash equivalents - end of period $ 5,873,490 $ 7,880,649 [1]
[1] See Note 7, Retrospective Adoption of New Accounting Principle